Anita Chakraverty

The dark genome—it sounds like a work of science fiction. Perhaps something Keanu starred in shortly after The Matrix? But for a dozen or so biotech companies, investigating this mysterious genetic “dark matter” is at least as exciting as anything dreamt up by a movie studio.

A major report on the NHS in England has warned that ethnic health inequalities could grow as a result of advances genomics and precision medicine unless disparities are addressed.

Analyzing the plasma proteins of patients with sepsis can provide information on its severity and prognosis, researchers report.

Millions of U.S. adults should no longer take cholesterol-lowering drugs under updated guidelines released by the American Heart Association (AHA) late last year, research indicates.

A self-taught artificial intelligence system can identify a common form of lung cancer from microscopy images and determine the likelihood that it will return after treatment as well as overall patient survival.

Medical mistrust has been identified as a key barrier in a major U.K. report on ethnic inequalities in genomics and precision medicine, released earlier this year by the NHS Race and Health Observatory.

Widespread, opportunistic testing for prostate specific antigen (PSA) could be contributing the overdiagnosis of prostate cancer across Europe, researchers warn.

Omitting the bolus, quick-delivery component of 5-fluorouracil in multi-drug chemotherapy regimens for advanced gastrointestinal cancers can reduce treatment toxicity without impacting survival, research suggests.

Researchers have discovered that five factors can predict response to checkpoint inhibitor chemotherapy across a wide variety of tumor locations, which could help in the personalization of cancer treatment.

A study suggests that machine learning may have helped cut hospitalizations by more than a quarter during the COVID-19 pandemic by determining how best to allocate limited medication and personalizing public health decision making.